The Vice President, Global Commercial Strategy Lead for Vaccines is responsible for driving long-range commercial strategy, portfolio management, and commercial success across both pipeline and inline brands. This role serves as the single, authoritative commercial voice to R&D, Business Development, and US & International Commercial Regions, establishing clear commercial leadership to improve portfolio decision-making and trade-offs, ensure optimal launch and brand marketing strategies, and maximize global patient impact and enterprise value realization for our Vaccine portfolio. Reporting to the Global Commercial Strategy Lead, this leader shapes decisions on Vaccine portfolio prioritization, lifecycle value optimization, and global marketing strategy. The position partners closely with R&D, Medical Affairs, Global Access & Value, and Regional Commercial teams to deliver breakthrough vaccines for the prevention of respiratory diseases, including pneumococcal disease, respiratory syncytial virus (RSV) and COVID-19. We’re also advancing vaccines for additional serious childhood, adolescent and adult infections, including meningococcal disease, Lyme disease, and C difficile. Success in this role requires a senior commercial strategist who combines scientific depth with decisive enterprise leadership. This leader must confidently engage in complex scientific and clinical discussions, synthesize insights across R&D, Access, and Commercial teams, and convert them into clear portfolio priorities and differentiated global strategies. With full accountability for value creation, the role requires strong P&L acumen and the ability to make disciplined trade‑offs that optimize lifecycle value, launch success, and long‑term portfolio performance. The Vaccine portfolio represents significant strategic value to realizing Pfizer's vision to achieve leadership via breakthroughs in prioritized diseases and biological axes to generate highly differentiated, multi-indication mega-blockbusters. Today, the Vaccines portfolio delivers more than $11B globally with 10 ongoing clinical studies underway to significantly expand our vaccine portfolio over the next several years.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive